These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23816429)

  • 1. Probing the association between dexamethasone-induced cortisol suppression and serotonin transporter availability among drug-free patients with major depressive disorder--a small-sample SPECT study with [¹²³I]ADAM.
    Tsai HC; Lin SH; Lee IH; Chen PS; Chen KC; Yeh TL; Yao WJ; Chiu NT; Lu RB; Yang YK
    Psychoneuroendocrinology; 2013 Nov; 38(11):2805-9. PubMed ID: 23816429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the dexamethasone suppression test and serotonin transporter availability in healthy volunteer: a SPECT with [(123)I] ADAM study.
    Tsai HY; Lee IH; Yeh TL; Yao WJ; Chen KC; Chen PS; Chiu NT; Lu RB; Yang YK
    Eur Neuropsychopharmacol; 2012 Sep; 22(9):641-6. PubMed ID: 22356823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower availability of midbrain serotonin transporter between healthy subjects with and without a family history of major depressive disorder - a preliminary two-ligand SPECT study.
    Hsieh PC; Chen KC; Yeh TL; Lee IH; Chen PS; Yao WJ; Chiu NT; Chen CC; Liao MH; Yang YK
    Eur Psychiatry; 2014 Sep; 29(7):414-8. PubMed ID: 24439516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study.
    Newberg AB; Amsterdam JD; Wintering N; Ploessl K; Swanson RL; Shults J; Alavi A
    J Nucl Med; 2005 Jun; 46(6):973-7. PubMed ID: 15937308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neither cortisol nor brain-derived neurotrophic factor is associated with serotonin transporter in bipolar disorder.
    Chou YH; Lirng JF; Hsieh WC; Chiu YC; Tu YA; Wang SJ
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):280-287. PubMed ID: 26706694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying midbrain serotonin transporter in depression: a preliminary study of diagnosis and naturalistic treatment outcome.
    Tsai HC; Lin SH; Chen PS; Chang HH; Lee IH; Yeh TL; Chen KC; Chiu NT; Yao WJ; Liao MH; Yang YK
    Pharmacopsychiatry; 2015 Mar; 48(2):58-64. PubMed ID: 25626060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study.
    Catafau AM; Perez V; Plaza P; Pascual JC; Bullich S; Suarez M; Penengo MM; Corripio I; Puigdemont D; Danus M; Perich J; Alvarez E
    Psychopharmacology (Berl); 2006 Dec; 189(2):145-53. PubMed ID: 17033844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the Serotonin Transporter Availability Among Male Cigarette Smokers: A SPECT Study With [123I] ADAM.
    Zhao RJ; Lin SH; Lee LT; Lee IH; Chen PS; Chen KC; Yang YK
    J Addict Med; 2016; 10(2):89-92. PubMed ID: 26742023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin transporter availability may moderate the association between perceiving stress and depressive tendencies - A SPECT with 5-HTTLPR genotyping study.
    Lin SH; Lee IH; Chen KC; Chen PS; Chiu NT; Yao WJ; Yang YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Aug; 61():24-9. PubMed ID: 25816791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.
    Yeh YW; Ho PS; Kuo SC; Chen CY; Liang CS; Yen CH; Huang CC; Ma KH; Shiue CY; Huang WS; Shyu JF; Wan FJ; Lu RB; Huang SY
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu120. PubMed ID: 25568284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No seasonal variation in human midbrain serotonin transporter availability in Taiwan.
    Cheng YS; Chen KC; Yang YK; Chen PS; Yeh TL; Lee IH; Chang YH; Liao MH
    Psychiatry Res; 2011 Dec; 194(3):396-399. PubMed ID: 22041533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced midbrain serotonin transporter availability in drug-naïve patients with depression measured by SERT-specific [(123)I] nor-beta-CIT SPECT imaging.
    Joensuu M; Tolmunen T; Saarinen PI; Tiihonen J; Kuikka J; Ahola P; Vanninen R; Lehtonen J
    Psychiatry Res; 2007 Feb; 154(2):125-31. PubMed ID: 17289353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incongruent reduction of serotonin transporter associated with suicide attempts in patients with major depressive disorder: a positron emission tomography study with 4-[18F]-ADAM.
    Yeh YW; Ho PS; Chen CY; Kuo SC; Liang CS; Ma KH; Shiue CY; Huang WS; Cheng CY; Wang TY; Lu RB; Huang SY
    Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25522405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin transporter availability in the midbrain and perceived social support in healthy volunteers.
    Huang HY; Lee IH; Chen KC; Lin SH; Yeh TL; Chen PS; Chiu NT; Yao WJ; Chen CC; Liao MH; Yang YK
    J Psychosom Res; 2013 Dec; 75(6):577-81. PubMed ID: 24290049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in serotonin transporter binding affinity in patients with major depressive disorder and night eating syndrome.
    Lundgren JD; Amsterdam J; Newberg A; Allison KC; Wintering N; Stunkard AJ
    Eat Weight Disord; 2009 Mar; 14(1):45-50. PubMed ID: 19367140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study of serotonin transporter availability and SLC6A4 gene polymorphisms in patients with major depression.
    Ho PS; Ho KK; Huang WS; Yen CH; Shih MC; Shen LH; Ma KH; Huang SY
    Psychiatry Res; 2013 Jun; 212(3):216-22. PubMed ID: 23149035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter binding with [123I]beta-CIT SPECT in major depressive disorder versus controls: effect of season and gender.
    Ruhé HG; Booij J; Reitsma JB; Schene AH
    Eur J Nucl Med Mol Imaging; 2009 May; 36(5):841-9. PubMed ID: 19183998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of serotonin transporters and its blockade by citalopram in patients with major depression using a novel SPECT ligand [123I]-ADAM.
    Herold N; Uebelhack K; Franke L; Amthauer H; Luedemann L; Bruhn H; Felix R; Uebelhack R; Plotkin M
    J Neural Transm (Vienna); 2006 May; 113(5):659-70. PubMed ID: 16465456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution volume ratio of serotonin and dopamine transporters in euthymic patients with a history of major depression - a dual-isotope SPECT study.
    Hsieh PC; Lee IH; Yeh TL; Chen KC; Huang HC; Chen PS; Yang YK; Yao WJ; Lu RB; Chiu NT
    Psychiatry Res; 2010 Dec; 184(3):157-61. PubMed ID: 21030217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between serotonin transporter availability and hostility scores in healthy volunteers - a single photon emission computed tomography study with [(123)I] ADAM.
    Yang YK; Yao WJ; Yeh TL; Lee IH; Chen KC; Lu RB
    Psychiatry Res; 2007 Apr; 154(3):281-4. PubMed ID: 17349781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.